Literature DB >> 31774240

Prevalence and correlates of adherence to skin examination among adolescent and young adult survivors of melanoma from the Project Forward Study.

Kimberly A Miller1,2, Katherine Y Wojcik1, Myles G Cockburn1,2,3,4, Gino K In2,5, Ann S Hamilton1, Joel E Milam1.   

Abstract

BACKGROUND: Melanoma is a common cancer among adolescents and young adults (AYAs), yet adherence to recommended surveillance and factors related to adherence are not well understood in this population. This study assessed the prevalence and correlates of physician-conducted skin examination (PSE) and skin self-examination (SSE) among AYA-aged long-term survivors of melanoma. PROCEDURES: Melanoma cases were identified from the Los Angeles County cancer registry and surveys were then completed by 128 respondents diagnosed between the ages 0 and 24, with stage 1 melanoma or higher, at least 5 years from diagnosis, and who were between the ages 18 and 39 at the time of survey.
RESULTS: Eighty-two percent of AYA melanoma survivors reported SSE within the past 6 months, while 65% reported annual PSE. Greater health care self-efficacy was positively associated with adherence to PSE, SSE, and both types of skin examinations (P < .01). Higher socioeconomic status and having a regular source of primary health care were positively associated with annual PSE and adherence to both surveillance practices (P < .05 and P < .01, respectively). Hispanic ethnicity was negatively associated with annual PSE compared to non-Hispanics (P < .01), and greater depressive symptoms were negatively associated with adherence to both skin examinations (P < .05).
CONCLUSIONS: High rates of SSE were observed, but PSE adherence was lower than optimal in this sample. Interventions to improve PSE are needed for at-risk AYA survivors of melanoma, and strategies that help melanoma survivors navigate the health care system and access primary care may facilitate greater adherence.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  adolescent; melanoma; skin examination; surveillance; survivorship; young adult

Mesh:

Year:  2019        PMID: 31774240      PMCID: PMC6980887          DOI: 10.1002/pbc.28090

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.838


  34 in total

1.  Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Authors:  Kevin C Oeffinger; Ann C Mertens; Melissa M Hudson; James G Gurney; Jacqueline Casillas; Hegang Chen; John Whitton; Mark Yeazel; Yutaka Yasui; Leslie L Robison
Journal:  Ann Fam Med       Date:  2004 Jan-Feb       Impact factor: 5.166

2.  Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999-2006.

Authors:  Xiao-Cheng Wu; Melody J Eide; Jessica King; Mona Saraiya; Youjie Huang; Charles Wiggins; Jill S Barnholtz-Sloan; Nicolle Martin; Vilma Cokkinides; Jacqueline Miller; Pragna Patel; Donatus U Ekwueme; Julian Kim
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

3.  Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.

Authors:  Megan M Moore; Alan C Geller; E Margaret Warton; Joan Schwalbe; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2015-08-19       Impact factor: 11.527

4.  End-of-Life Transitions and Hospice Utilization for Adolescents: Does Having a Usual Source of Care Matter?

Authors:  Jessica Keim-Malpass; Lisa C Lindley
Journal:  J Hosp Palliat Nurs       Date:  2017-08       Impact factor: 1.918

5.  Examining the pathways linking lower socioeconomic status and advanced melanoma.

Authors:  Ricardo A Pollitt; Susan M Swetter; Timothy M Johnson; Pratima Patil; Alan C Geller
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

Review 6.  Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials.

Authors:  W Archie Bleyer
Journal:  Med Pediatr Oncol       Date:  2002-01

7.  A Retrospective Analysis of Surveillance Adherence of Patients after Treatment of Primary Cutaneous Melanoma.

Authors:  Jeave Reserva; Monica Janeczek; Cara Joyce; Amanda Goslawski; Hwala Hong; Feng-Ning Yuan; Neelam Balasubramanian; Laura Winterfield; James Swan; Rebecca Tung
Journal:  J Clin Aesthet Dermatol       Date:  2017-12-01

8.  General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey.

Authors:  Eugene Suh; Christopher K Daugherty; Kristen Wroblewski; Hannah Lee; Mackenzie L Kigin; Kenneth A Rasinski; Jennifer S Ford; Emily S Tonorezos; Paul C Nathan; Kevin C Oeffinger; Tara O Henderson
Journal:  Ann Intern Med       Date:  2014-01-07       Impact factor: 25.391

Review 9.  A Global Review of Melanoma Follow-up Guidelines.

Authors:  Shannon C Trotter; Novie Sroa; Richard R Winkelmann; Thomas Olencki; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

10.  Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.

Authors:  Paul C Nathan; Mark L Greenberg; Kirsten K Ness; Melissa M Hudson; Ann C Mertens; Martin C Mahoney; James G Gurney; Sarah S Donaldson; Wendy M Leisenring; Leslie L Robison; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 50.717

View more
  2 in total

1.  Skin Cancer in People of Color: A Systematic Review.

Authors:  George A Zakhem; Akshay N Pulavarty; Jenna C Lester; Mary L Stevenson
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

2.  Long-term care, care needs and wellbeing of individuals after cancer in childhood or adolescence (VersKiK): study protocol of a large scale multi-methods non-interventional study.

Authors:  E Aleshchenko; E Swart; C Spix; M Voigt; P Trocchi; T Langer; G Calaminus; K Baust; J Glogner; P Ihle; J Küpper-Nybelen; C Lüpkes; T Kloppe; D Horenkamp-Sonntag; I Meier; U Marschall; P Dröge; M Klein; A Weiss; C Apfelbacher
Journal:  BMC Health Serv Res       Date:  2022-09-20       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.